Femodene ED Combination* Tablet POM, R x84

Sugar-coated tablets - each active tablet contains 75 micrograms gestodene and 30 micrograms ethinylestradiol.

Therapeutic indications:
• Oral contraception and the recognised gynaecological indications for such oestrogen progestogen combinations.
• The decision to prescribe Femodene ED should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Femodene ED compares with other combined hormonal contraceptives (CHCs)

Features

Nature and contents of container:
• Deep drawn strips made of polyvinyl chloride film with counter-sealing foil made of aluminium with heat sealable coating.
• Presentation - each carton contains either 1 or 3 blister memo-packs.
• Each blister memo-pack contains 21 active tablets and 7 placebo tablets.

Special precautions for storage:
• Do not store above 25°C.
• Protect from light